Psychemedics Retained Earnings (Accumulated Deficit) 2010-2024 | PMD

Psychemedics retained earnings (accumulated deficit) from 2010 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.
Psychemedics Annual Retained Earnings (Accumulated Deficit)
(Millions of US $)
2023 $-17
2022 $-12
2021 $-10
2020 $-9
2019 $-4
2018 $-1
2017 $-2
2016 $-5
2015 $-8
2014 $-7
2013 $-7
2012 $-7
2011 $-7
2010 $-8
2009 $-8
Psychemedics Quarterly Retained Earnings (Accumulated Deficit)
(Millions of US $)
2024-06-30 $-18
2024-03-31 $-17
2023-12-31 $-17
2023-09-30 $-16
2023-06-30 $-14
2023-03-31 $-13
2022-12-31 $-12
2022-09-30 $-11
2022-06-30 $-10
2022-03-31 $-10
2021-12-31 $-10
2021-09-30 $-8
2021-06-30 $-8
2021-03-31 $-9
2020-12-31 $-9
2020-09-30 $-8
2020-06-30 $-7
2020-03-31 $-5
2019-12-31 $-4
2019-09-30 $-2
2019-06-30 $-2
2019-03-31 $-2
2018-12-31 $-1
2018-09-30 $-1
2018-06-30 $-1
2018-03-31 $-2
2017-12-31 $-2
2017-09-30 $-4
2017-06-30 $-4
2017-03-31 $-4
2016-12-31 $-5
2016-09-30 $-6
2016-06-30 $-8
2016-03-31 $-9
2015-12-31 $-8
2015-09-30 $-8
2015-06-30 $-8
2015-03-31 $-7
2014-12-31 $-7
2014-09-30 $-6
2014-06-30 $-7
2014-03-31 $-7
2013-12-31 $-7
2013-09-30 $-7
2013-06-30 $-7
2013-03-31 $-7
2012-12-31 $-7
2012-09-30 $-7
2012-06-30 $-7
2012-03-31 $-7
2011-12-31 $-7
2011-09-30 $-7
2011-06-30 $-7
2011-03-31 $-8
2010-12-31 $-8
2010-09-30 $-8
2010-06-30 $-8
2010-03-31 $-8
2009-12-31 $-8
2009-09-30 $-8
2009-06-30 $-8
2009-03-31 $-7
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.014B $0.022B
Psychemedics Corporation provides testing services for the detection of abused substances through the analysis of hair samples. Their testing methods utilize a patented technology for performing immunoassays on enzymatically dissolved hair samples with confirmation testing by mass spectrometry.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.039B 12.12
Quest Diagnostics (DGX) United States $17.877B 18.12
DaVita (DVA) United States $12.667B 16.38
Encompass Health (EHC) United States $10.405B 24.53
Chemed (CHE) United States $8.459B 26.00
Elanco Animal Health (ELAN) United States $7.054B 16.79
RadNet (RDNT) United States $6.388B 141.61
Option Care Health (OPCH) United States $3.890B 18.43
Amedisys (AMED) United States $3.035B 21.60
LifeStance Health (LFST) United States $2.828B 0.00
Addus HomeCare (ADUS) United States $2.320B 27.22
Astrana Health (ASTH) United States $2.297B 36.01
U.S Physical Therapy (USPH) United States $1.428B 37.54
Pennant (PNTG) United States $1.162B 46.99
Aveanna Healthcare Holdings (AVAH) United States $1.149B 0.00
Atai Life Sciences (ATAI) Germany $0.265B 0.00
Daxor (DXR) United States $0.042B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00